Latest News

Shares of semiconductor materials supplier Entegris (NASDAQ:ENTG) fell 8.6% in the afternoon session after the company reported weak first quarter 2025 results which lacked standout positives, with revenue falling short of estimates and next quarter's revenue guidance missing significantly. The real concern came from the company's second-quarter outlook, which called for up to a 5% revenue decline sequentially and EBITDA margin compression, weighed by tariffs and weak U.S. sales to China. Overall, this quarter could have been better.

Shares of healthcare services company Agilon Health (NYSE:AGL) fell 24.9% in the afternoon session after the company reported weak first quarter 2025 results as new customer additions fell short. 

Shares of water handling and recycling company Aris Water (NYSE:ARIS) fell 15.7% in the afternoon session after the company reported mixed first quarter 2025 results: its EBITDA guidance for next quarter missed. While management kept its full-year EBITDA outlook unchanged, second-quarter guidance implied a sequential decline due to deferred maintenance and lower skim oil prices. On the other hand, ARIS significantly beat analysts' revenue, EPS, and EBITDA expectations. Still, we think this was a weaker print.

FCOJ closed lower and the trends remain down in the market.

Shares of personal care company Edgewell Personal Care (NYSE:EPC) fell 12.4% in the afternoon session after the company reported weak first quarter 2025 results which included a beat on EBITDA expectations, but organic revenue missed and full-year EBITDA guidance fell short of Wall Street estimates. North American sales dragged things down, especially in shaving, feminine care, and sun products. Sales were down just over 3%, and while gross margins improved a bit from cost cuts, that couldn't offset lower volumes. What's more, EPC lowered their full-year sales and EBITDA outlook. Overall, this was a softer quarter.

XAU/USD drops as risk appetite improves, traders await Powell's remarks.

Shares of online advertising giant Alphabet (NASDAQ:GOOGL) fell 8.2% in the afternoon session after Apple's top services chief, Eddy Cue, said the company was testing AI search tools like Perplexity for Safari, hinting at a big change in how people search for information on Apple devices. This could hit Google hard, given that "search" is its bread and butter, and it pays (reportedly) Apple $20 billion annually to remain the default search engine on its devices. 

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 36% in the afternoon session after the company reported mixed first quarter 2025 results: it lowered its full-year revenue, EPS, and EBITDA guidance due to weaker trends in its pharmacogenomics and hereditary cancer testing (women's health) businesses. On the other hand, MYGN significantly beat analysts' EPS and EBITDA expectations. Overall, this was a softer quarter.

Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 20.5% in the afternoon session after the company reported weak first quarter 2025 results which featured drastically lowered full-year 2025 product revenue guidance and a major increase in operating expenses. 

Shares of natural food company Hain Celestial (NASDAQ:HAIN) fell 49% in the afternoon session after the company reported underwhelming first quarter 2025 results as it missed across revenue, EPS, and EBITDA, and its full-year EBITDA guidance fell short of Wall Street's estimates. Revenue was down 11%, and margins slipped a bit too, hurt by heavier discounting and slower demand. Overall, this quarter could have been better.

Shares of cybersecurity company CrowdStrike (NASDAQ:CRWD) fell 5.1% in the morning session after the company announced a 5% cut to its workforce as part of efforts to stay more efficient using AI, though it planned to continue filling strategic roles in the current year. As part of the plan, the company expects to incur restructuring expenses, which could negatively affect its earnings in the year, and it is not clear if it will immediately offset the costs using its new efficiency plans.

Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

The $50.00 strike price put for the July 18 exercise period, which is 14.5% below today's price, is showing an unusual open interest in that contract. There is an increase of 7,804 put contracts.

Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 22.2% in the afternoon session after the company reported weak first quarter 2025 results which included a significant miss on full-year EPS guidance and EPS falling short of Wall Street's estimates. Sales were flat, with a slight drop in PYLARIFY mostly offset by small gains in other parts of the business. Operating profit also fell. The real issue was the cut to full-year earnings, now seen at $6.60 to $6.70 per share, well below the $7.00 to $7.20 range it gave before. Overall, this was a softer quarter.

Shares of beauty products company Coty (NYSE:COTY) fell 10% in the afternoon session after the company reported mixed first quarter 2025 results which significantly beat analysts' EBITDA expectations, but revenue and EPS missed (though organic revenue beat). Organic sales in the Prestige segment dipped 2.5%, reflecting softer fragrance demand and a tough comparison from blockbuster launches last year, while Consumer Beauty sales fell 5% organically due to continued weakness in color cosmetics. Zooming out, we think this was a decent quarter featuring some areas of strength but also some blemishes. The areas below expectations seem to be driving the move.

Shares of aI-powered lending platform Upstart (NASDAQ:UPST) fell 11.1% in the afternoon session after the company reported first quarter 2025 results which were overshadowed by concerns after announcing Fortress would purchase up to $1.2 billion of loans, raising questions about liquidity and lending capacity. This raised questions about balance sheet health (Upstart needs liquidity) and future lending capacity. The quarter itself was decent with sales, EBITDA and EPS topping estimates while full year guidance was slightly lifted.

Shares of uniform rental provider Vestis Corporation (NYSE:VSTS) fell 37.5% in the afternoon session after the company reported disappointing first-quarter 2025 results, which missed across the board and included guidance that fell well short of expectations. The big hit came from lost deals and weaker sales to current clients, along with the loss of a big national account. Revenue dropped 6%, and even after removing a one-time charge, profit still fell from last year. The company gave a weak outlook for next quarter and pulled its full-year forecast, pointing to shaky demand. There were no redeeming qualities here.

Rivian analysts remain cautious on the stock's short-term outlook ahead of the R2 launch in 2026.

AMD reports better-than-expected quarterly results on Tuesday in what CEO Lisa Su calls "an outstanding start to 2025." Analysts weigh in on the report.